|View printer-friendly version|
|October 13, 2004 5:19 p.m.|
|Teva Announces Approval Of Flumazenil Injection|
Jerusalem, Israel, October 13, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.